Medisphere AX
The single source of truth for surgical device performance
We are building the definitive real-world evidence layer for the $400 billion global surgical consumables and implants market.
- Digitises the exact paper form surgeons already use → >98 % same-day capture
- Delivers instant, regulator-grade PSUR/PMCF data
- Creates the only blinded benchmark pool that shows every manufacturer precisely how they perform against the entire market in real theatres
No competitor offers zero-friction adoption + real-time head-to-head comparison + multi-centre trial capability in one platform.
Traction
- First potential contract with a Medical Device manufacturer
- Blinded pool launches 2027 → £100 million+ valuation overnight
Financials
Year 3: £10.6 million ARR, £4 million EBITDA
Year 7: £120 million+ ARR, £6–12 billion exit path
Medisphere AX is the next Veeva/Greenlight Guru of post-market evidence: a regulated, recurring-revenue platform that becomes mandatory once the data moat exists.
The Bloomberg Terminal for surgical devices is being built right now.